Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q2 EPS by 1c

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q2 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• Uni-Fuels raises full-year revenue guidance after strong first half
• William Blair on Braze Inc (BRZE): 'We expect AI to add another vector to growth'